Abstract:Parathyroid hormone (PTH) receptor (PTHR) is a medically important family B G Protein Coupled Receptor (GPCR) that primarily couples to Gs/cAMP and Gq/Ca2+ signaling pathways and has a central role in regulating Ca2+ homeostasis and bone turnover. PTHR is activated by two endogenous hormones, endocrine PTH and paracrine PTH related protein (PTHrP), but only PTH mediates prolonged activation of the receptor and sustained cAMP responses after receptor internalization to the endosomes. To investigate the structural basis of prolonged activation of PTHR, we employed cryo‐EM and solved the high resolution (3Å) structure of PTHR coupled to Gs and activated by long‐acting PTH (LA‐PTH), an analog of PTH that remarkably sustains endosomal PTHR signaling and induces significantly prolonged elevation in blood calcium in mice and monkeys. LA‐PTH binds the receptor as a single extended α‐helix with its N‐terminus inserted deep into the transmembrane domain (TMD) of the receptor, while positioning the extracellular domain (ECD) of PTHR perpendicular to the cell membrane. The receptor activating N‐terminal half of LA‐PTH forms a dense network of hydrophobic and polar interactions with receptor's TMD resulting in a tight binding and giving structural basis for remarkably sustained activation of PTHR by LA‐PTH. Binding of LA‐PTH activates the receptor by inducing partial unwinding of the C‐terminus of transmembrane helix 6 (TM6) and a sharp kink at the middle of this helix, a hallmark of family B GPCR activation. This results in a pronounced outward movement of TM6, opening the cytosolic cavity of the receptor, which allows subsequent G protein coupling. Additionally, our cryo‐EM data revealed structural dynamics of PTHR demonstrated by the ability of receptor ECD to adopt multiple conformational states. Together, these results reveal the structural determinants of PTHR signaling and provide a molecular framework for structure‐based design of novel therapeutics for osteoporosis and hypocalcaemia treatment.Support or Funding InformationNIH R01 DK116780, DK102495 and DK111427 awarded to JPV; the Jay and Betty Van Andel Foundation and NIH GM127710 grants awarded to EXThis abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2

Structure and Dynamics of the Active Human Parathyroid Hormone Receptor-1.

Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1

Structural Basis of Activation and Sustained Signaling by the PTH Receptor

Identification and Structure-Function Analyses of an Allosteric Inhibitor of the Tyrosine Phosphatase PTPN22.

Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation

Unraveling the Interplay of Extracellular Domain Conformational Changes and Parathyroid Hormone Type 1 Receptor Activation in Class B1 G Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models

Visualization of the Parathyroid Hormone Receptor in Long-Active States

Structural Basis for Activation of the Growth Hormone-Releasing Hormone Receptor.

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E<sub>2</sub> receptor EP2 subtype

Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates.

A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2

Phase-plate Cryo-Em Structure of a Class B GPCR–G-protein Complex

Epigenetic profiling reveals key genes and cis-regulatory networks specific to human parathyroids

Crystal Structure and Substrate Specificity of PTPN12.

Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome

Conserved class B GPCR activation by a biased intracellular agonist

Molecular and structural basis of the dual regulation of the polycystin-2 ion channel by small-molecule ligands

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor

Classification of Barrett's epithelium by magnifying endoscopy.